Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
320.8 INR | +2.00% | +3.77% | +1.36% |
Apr. 04 | Gufic Biosciences Forms New Wholly-Owned Arm in Dubai | MT |
Apr. 03 | Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai | CI |
Sales 2022 | 7.79B 93.52M | Sales 2023 | 6.91B 82.9M | Capitalization | 18.09B 217M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.5M | Net income 2023 | 797M 9.57M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.34M | Net Debt 2023 | 3.06B 36.68M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 22.34% |
Latest transcript on Gufic Biosciences Limited
1 day | +2.00% | ||
1 week | +3.77% | ||
Current month | +13.54% | ||
1 month | +7.83% | ||
3 months | -7.94% | ||
6 months | +27.11% | ||
Current year | +1.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 64 | 86-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 320.8 | +2.00% | 78 750 |
24-04-24 | 314.4 | -1.93% | 89,409 |
24-04-23 | 320.6 | +7.49% | 386,107 |
24-04-22 | 298.3 | +0.59% | 70,520 |
24-04-19 | 296.6 | -2.95% | 157,093 |
Delayed Quote NSE India S.E., April 25, 2024 at 09:03 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.56% | 358B | |
+19.26% | 322B | |
+8.05% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.67% | 149B | |
-6.80% | 146B |
- Stock Market
- Equities
- GUFICBIO Stock
- GUFICBIO Stock